Recent advances in gout drugs

C Shi, Z Zhou, X Chi, S Xiu, C Yi, Z Jiang… - European Journal of …, 2023 - Elsevier
Gout is an autoinflammatory disease caused by the deposition of urate crystals. As the most
common inflammatory arthritis, gout has a high incidence and can induce various severe …

Agents for the treatment of gout: current advances and future perspectives

X Zeng, Y Liu, Y Fan, D Wu, Y Meng… - Journal of Medicinal …, 2023 - ACS Publications
Gout is characterized by hyperuricemia and the deposition of monosodium urate (MSU)
crystals around joints. Despite the availability of several drugs on the market, its treatment …

TMEM16E regulates endothelial cell procoagulant activity and thrombosis

AA Schmaier, PF Anderson, SM Chen… - The Journal of …, 2023 - Am Soc Clin Investig
Endothelial cells (ECs) normally form an anticoagulant surface under physiological
conditions, but switch to support coagulation following pathogenic stimuli. This switch …

Lacticaseibacillus rhamnosus Fmb14 prevents purine induced hyperuricemia and alleviate renal fibrosis through gut-kidney axis

H Zhao, X Chen, L Zhang, F Meng, L Zhou… - Pharmacological …, 2022 - Elsevier
Hyperuricemia is a critical threat to human health, and conventional medical treatment only
aims to treat acute gouty arthritis. Purine diet-mediated chronic hyperuricemia and related …

The role of ABCG2 in the pathogenesis of primary hyperuricemia and gout—an update

R Eckenstaler, RA Benndorf - International Journal of Molecular Sciences, 2021 - mdpi.com
Urate homeostasis in humans is a complex and highly heritable process that involves ie,
metabolic urate biosynthesis, renal urate reabsorption, as well as renal and extrarenal urate …

The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment

S Tong, P Zhang, Q Cheng, M Chen, X Chen… - Frontiers in Cellular …, 2022 - frontiersin.org
Numerous studies have demonstrated that gut microbiota is essential for the host's health
because it regulates the host's metabolism, endocrine, and immune systems. In recent …

Structural basis for the transport and substrate selection of human urate transporter 1

J He, G Liu, F Kong, Q Tan, Z Wang, M Yang, Y He… - Cell Reports, 2024 - cell.com
High serum urate levels are the major risk factor for gout. URAT1, the primary transporter for
urate absorption in the kidneys, is well known as an anti-hyperuricemia drug target …

Superiority of low‐dose benzbromarone to low‐dose febuxostat in a prospective, randomized comparative effectiveness trial in gout patients with renal uric acid …

F Yan, X Xue, J Lu, N Dalbeth, H Qi, Q Yu… - Arthritis & …, 2022 - Wiley Online Library
Objective The predominant mechanism driving hyperuricemia in gout is renal uric acid
underexcretion; however, the standard urate‐lowering therapy (ULT) recommendation is first …

Sustainable quantitative determination of allopurinol in fixed dose combinations with benzbromarone and thioctic acid by capillary zone electrophoresis and …

HS Elbordiny, SM Elonsy, HG Daabees… - … Chemistry and Pharmacy, 2022 - Elsevier
The design of novel validated methodologies targeting many goals such as simplicity,
greenness, analytical efficiency and sustainability, has gained great concern in quality …

Emerging urate-lowering drugs and pharmacologic treatment strategies for gout: a narrative review

R Terkeltaub - Drugs, 2023 - Springer
Hyperuricemia with consequent monosodium urate crystal deposition leads to gout,
characterized by painful, incapacitating inflammatory arthritis flares that are also associated …